Dane o zamówieniach publicznych i dotacjach w Europie z oficjalnych rejestrów · Stan danych: 17 listopada 2026, aktualizacja codzienna.

Program dotacji · Stany Zjednoczone

Extramural Research Programs in the Neurosciences and Neurological Disorders

Extramural Research Programs in the Neurosciences and Neurological Disorders (Stany Zjednoczone): nabory i dotacje programu. Nabory na stronie: 129, w tym otwarte teraz: 36; zwykle otwierane są w listopadzie. Stan danych: 17 listopada 2026, aktualizacja codzienna.

Instytucja finansująca: National Institutes of Health (Department of Health and Human Services)

Dotacje z ostatnich 24 miesięcy
0
Beneficjenci
0
Otwarte nabory
36
Nabory na stronie
129

Nabory otwierane są zwykle w listopadzie

O programie

Objectives: (1) To support extramural research funded by the National Institute of Neurological Disorders and Stroke (NINDS) including: basic research that explores the fundamental structure and function of the brain and the nervous system; research to understand the causes and origins of…

Więcej w źródle

Otwarte nabory

NabórStatusZakończenie naboru
NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional) (nabór 11.2024 – 11.2026)Otwarty19 listopada 2026
Translational Neural Devices (R61/R33 - Clinical Trial Optional) (nabór 10.2024 – 01.2027)Otwarty28 stycznia 2027
Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional) (nabór 12.2024 – 10.2027)Otwarty8 października 2027
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)Otwarty20 października 2027
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed) (nabór 10.2024 – 10.2027)Otwarty20 października 2027
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed) (nabór 11.2024 – 10.2027)Otwarty20 października 2027
Limited Competition: Renewal of Existing NINDS-Supported Clinical Trial Cooperative Agreement Awards (U01 - Clinical Trials Required)Otwarty5 listopada 2027
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed) (nabór 12.2024 – 11.2027)Otwarty12 listopada 2027
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required) (nabór 12.2024 – 11.2027)Otwarty12 listopada 2027
Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)Otwarty7 stycznia 2028
NINDS Efficacy and Exploratory Clinical Trials (UG3/UH3 - Clinical Trial Required)Otwarty9 marca 2029
NIH Stroke Clinical Trials Network (StrokeNet) Infrastructure – National Coordinating Center (NCC) and National Data Management Center (NDMC)Planowany—
Investigate Novel Therapeutic Interventions and Testing Strategies for Neurological Disorders Including to Treat, Modify and Prevent the Development of Epilepsy (U24 Clinical Trial Not Allowed)Planowany—
Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) Infrastructure – Clinical Coordinating Center (CCC) & Data Coordinating Center (DCC)Planowany—
Centers without Walls for mechanisms of neurodegeneration in Alzheimer’s disease-related dementias (ADRD)Planowany—
HEAL Initiative: Program to Reveal and Evaluate Cells-to-gene Information that Specify Intricacies, Origins and the Nature of (PRECISION) Human Pain NetworkPlanowany—
Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) Infrastructure – Clinical Coordinating Center (CCC) and Data Coordinating Center (DCC)Planowany—
HEAL Initiative: Optimization of Therapeutic Medical Devices through Team Science Mechanistic Research (RM1)Planowany—
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Therapeutic Agent IdentificationPlanowany—
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and DevelopmentPlanowany—
Undiagnosed Diseases Network (UDN) Diagnostic Research Innovation CenterPlanowany—
Research to Improve Rigor, Replicability, and Reproducibility in Biomedical and Behavioral SciencesPlanowany—
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)Planowany—
Undiagnosed Diseases Network (UDN) Clinical and Data Coordinating CenterPlanowany—
Forecast for NIH Blueprint and BRAIN Initiative ACTION Potential Program (F99/K00 Clinical Trial Not Allowed)Planowany—
NIH Stroke Clinical Trials Network (StrokeNet) Infrastructure – Regional Coordinating Stroke Centers (RCCs)Planowany—
Clinical Trials and Ancillary Studies Conducted within NIH-Funded Clinical Trial Research Networks (UG3/UH3 - Clinical Trial Required)Planowany—
Functional Target Validation for Alzheimer's Disease-Related DementiasPlanowany—
Undiagnosed Diseases Network (UDN) Clinical Networks of Diagnostic ExcellencePlanowany—
Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Cerebroprotection – Network Sites and Coordinating Center (U01- CT Not Allowed)Planowany—

Kalendarze naborów

Dotacje na projekty rozpoczęte od 17 listopada 2024 do 17 listopada 2026; kwoty w euro po kursie Eurostatu z danego roku.

Pytania i odpowiedzi

Extramural Research Programs in the Neurosciences and Neurological Disorders: kiedy są nabory?
Otwarte teraz (36): NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and P… (19 listopada 2026), Translational Neural Devices (R61/R33 - Clinical Trial Optional) (28 stycznia 2027), Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neu… (8 października 2027), …. Nabory otwierane są zwykle w listopadzie.